Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Last revision Both sides next revision
fibromyalgia [2015/09/20 17:00]
sflitman
fibromyalgia [2015/09/20 17:10]
sflitman
Line 4: Line 4:
  
 ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
-Mild Cognitive Impairment and Mild AD | Intravenous anti-amyloid antibody ​ |  II  |  Yes  |  16%  |  52 weeks  |  1+ years  | +Fibromyalgia, ​Moderate ​or Severe | Alpha-2-delta antagonist ​ ​| ​ III  |  Yes  |  ​25%  |  ​12 weeks  |  ​52 weeks  |
-Moderate ​and Severe ​AD with Agitation  ​Novel oral agent |  II  |  Yes  |  50%  |  12 weeks  |  24 weeks  | +
-| Mild AD | Intravenous ​ mAb antibody ​ ​| ​ III  |  Yes  |  ​50%  |  ​18 weeks  ​|   ​Yes ​  | +
-| Mild to Moderate AD | Oral nicotinic alpha-7 ligand ​|  ​III  |  Yes  |  33%  |  26 weeks  |  26 weeks  |+
  
 ====== Response Form ====== ====== Response Form ======
Line 21: Line 18:
 <form method=post action="​http://​neurozone.org/​cgi-n/​emailform.cgi"> ​ <form method=post action="​http://​neurozone.org/​cgi-n/​emailform.cgi"> ​
 <input type=hidden name="​_site"​ value="​Clinical Research Inquiry"> ​ <input type=hidden name="​_site"​ value="​Clinical Research Inquiry"> ​
-<input type=hidden name="​_link"​ value="​http://​neurozone.org/​research/">  +<input type=hidden name="​_link"​ value="​http://​neurozone.org/​wiki/doku.php?​id=fibromyalgia">  
-<input type=hidden name=trialtype value="​Alzheimer'​s Disease">+<input type=hidden name=trialtype value="​Fibromyalgia">
 <table border=2 cellspacing=0 cellpadding=2> ​ <table border=2 cellspacing=0 cellpadding=2> ​
  <​tr> ​  <​tr> ​
Print/export
QR Code
QR Code fibromyalgia (generated for current page)